Skip to content
Home/ Circulating Tumor Cells, from Biotech Innovation to Clinical Utility Part B: Volume 392
Circulating Tumor Cells, from Biotech Innovation to Clinical Utility Part B: Volume 392

Circulating Tumor Cells, from Biotech Innovation to Clinical Utility Part B: Volume 392

No customer reviews yet ISBN 9780443136559

Circulating Tumor Cells, From Biotech Innovation to Clinical Utility Part B, Volume 392 in the International Review of Cell and Molecular Biology series, highlights new advances in the field, with this new volume presenting interesting chapters on a variety of timely topics, including Circulating Tumor Cells in Lung Cancer: integrating stemness and heterogeneity to improve clinical utility, Multi-omic Features and Clustering Phenotypes of Circulating Tumor Cells Associated with Metastasis and Clinical Outcomes, CTCs in CRC: updates, Proteomics and post-translational modification analysis in CTCs, Latest advances of CTC studies in prostate cancer, and Epigenetics and CTCs: new biomarkers and impact on tumor biology.

About the author

Product details

Pub dateJun 5, 2025
ISBN-100443136556
ISBN-139780443136559
LanguageEnglish
Last updated 2026-09-08 03:46
$276.35
In stock — ships in 24 hours with free tracking
Delivery by Monday, September 14, 2026
Qty
Sign in to Add to Saved list
Free delivery on orders over $35.
15-day returns. Any reason.
Secure checkout. We never store card details.

Readers who bought this also bought

More from Life Sciences - Developmental Biology
See all